S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.09
+360.19
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.52
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
18.51
+1.83
+10.97%
SANA · Sana Biotechnology, Inc.
NASDAQ NMS - GLOBAL MARKET - Real Time Price • USD
Sana Biotechnology Inc (SANA)
NASDAQ NMS - GLOBAL MARKET
Biotechnology
$2.35
-0.01
(-0.42%)
● At close: October 21 at 4:00:00 PM EDT
DAY'S RANGE
$2.35
$2.32
$2.38
52-WEEK RANGE
$2.35
$2.22
$5.90
What's happening
- SANA is down 0.42% today, trading at $2.35. — Live quote
- Volume today (95,643) is well below its 3-month average of 3,276,820. (Finnhub fundamentals)
- Reports earnings on 2026-11-05 (after market close), 14 days away. (Finnhub earnings calendar)
- Last quarter's EPS missed estimates: $-0.22 actual vs. $-0.15 estimated (-47.9%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 6
Buy 7
Hold 2
Sell 0
Strong sell 0
Aggregate ratings for 2026-10-01 (15 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
SANA
-42.01%
vs S&P 500
-54.79%
1-YEAR RETURN
SANA
-57.55%
vs S&P 500
-72.12%
6-MONTH RETURN
SANA
-31.99%
3-MONTH RETURN
SANA
-25.32%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$-0.22
Est. $-0.15
MISS -47.9%
2026-04-26 (Q1 2026)
$-0.17
Est. $-0.17
BEAT +1.7%
2026-01-26 (Q4 2025)
$-0.21
Est. $-0.14
MISS -55.0%
2025-10-26 (Q3 2025)
$-0.16
Est. $-0.18
BEAT +12.8%
Valuation Measures & Ratios
Enterprise Value4$646.4M
Forward P/E5—
PEG Ratio6—
Price / Sales (TTM1)—
Price / Book76.28
EV4 / Revenue—
EV4 / EBITDA—
Profit Margin—
Operating Margin—
Return on Equity (ROE8)-134.49%
Return on Assets (ROA9)-51.12%
Avg Volume (3M)3,276,820
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $1.01B | $797.0M | $935.2M | $656.6M | $395.1M |
| P/E | -4.08 | -3.43 | -3.81 | -2.59 | -1.48 |
| Price/Book | 6.51 | 6.68 | 4.79 | 5.36 | 1.89 |
| ROE | -159.67% | -195.03% | -125.58% | -206.77% | -127.74% |
| ROA | -57.19% | -62.25% | -56.33% | -70.07% | -59.95% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short38,725,699
Change from Prior Settlement-6.40%
% of Float—
Days to Cover (Short Ratio)8.96
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Latest SEC filing is Form 4, filed 2026-10-06; review it for current changes and risks. SEC EDGAR ↗
Potential concerns
- Trailing 52-week price return is -57.6%. Finnhub market metrics ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on SANA
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Operating income | -$65.4M | -$48.6M | -$43.5M | -$95.0M | -$50.6M | -$61.8M | -$49.4M | -$110.7M |
| Net income | -$63.6M | -$47.2M | -$42.2M | -$93.8M | -$49.4M | -$59.9M | -$50.3M | -$107.5M |
| EPS (diluted) | $-0.22 | $-0.17 | $-0.16 | $-0.39 | $-0.21 | $-0.25 | $-0.21 | $-0.49 |
| EPS (basic) | $-0.22 | $-0.17 | $-0.16 | $-0.39 | $-0.21 | $-0.25 | $-0.21 | $-0.49 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $431.5M | $373.6M | $416.9M | $435.4M | $361.6M | $445.5M | $501.0M | $559.4M |
| Total liabilities | $277.0M | $254.4M | $256.0M | $240.1M | $239.1M | $236.4M | $250.5M | $266.9M |
| Stockholders' equity | $154.6M | $119.2M | $160.9M | $195.3M | $122.6M | $209.1M | $250.5M | $292.5M |
| Total current assets | $170.6M | $111.7M | $148.7M | $161.8M | $82.5M | $112.7M | $160.8M | $210.1M |
| Total current liabilities | $123.8M | $86.3M | $78.7M | $35.5M | $33.4M | $33.2M | $45.4M | $47.0M |
| Cash & equivalents | $57.1M | $83.8M | $71.9M | $103.4M | $71.3M | $96.1M | $127.6M | $127.0M |
| Marketable securities (current) | $103.4M | $17.3M | $66.5M | $49.7M | $1.4M | $8.6M | $24.9M | $72.0M |
| Marketable securities (non-current) | — | — | — | — | — | — | — | — |
| Property, plant & equipment | $25.2M | $25.7M | $26.9M | $29.9M | $33.1M | $73.7M | $77.3M | $82.8M |
| Goodwill | $140.6M | $140.6M | $140.6M | $140.6M | $140.6M | $140.6M | $140.6M | $140.6M |
| Intangible assets | $59.2M | $59.2M | $59.2M | $59.2M | $59.2M | $59.2M | $59.2M | $59.2M |
| Other non-current assets | $552.0K | $563.0K | $3.2M | $3.2M | $3.2M | $4.4M | $5.1M | $5.6M |
| Accounts payable | $1.4M | $2.1M | $1.7M | $1.9M | $2.3M | $989.0K | $5.2M | $3.0M |
| Other non-current liabilities | $9.5M | $9.8M | $10.6M | $7.9M | $8.2M | $9.4M | $9.9M | $7.5M |
| Common stock & paid-in capital | $30.0K | $27.0K | $27.0K | $26.0K | $23.0K | $23.0K | $22.0K | $22.0K |
| Retained earnings | -$1.96B | -$1.90B | -$1.85B | -$1.79B | -$1.75B | -$1.65B | -$1.60B | -$1.56B |
| Accumulated other comprehensive income (loss) | -$66.0K | -$2.0K | $28.0K | $21.0K | $0 | $0 | $14.0K | $54.0K |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$32.8M | -$37.4M | -$32.6M | -$29.4M | -$33.1M | -$48.7M | -$47.2M | -$51.8M |
| Investing cash flow | -$87.5M | $49.4M | -$16.5M | -$48.0M | $7.7M | $16.6M | $47.1M | $41.8M |
| Financing cash flow | $93.6M | -$128.0K | $17.6M | $109.5M | $561.0K | $982.0K | $643.0K | $2.1M |
| Free cash flow | -$34.4M | -$37.7M | -$33.5M | -$29.5M | -$33.0M | -$48.8M | -$47.6M | -$55.9M |
| Capital expenditures | $1.6M | $288.0K | $873.0K | $41.0K | -$112.0K | $136.0K | $436.0K | $4.1M |
| Share-based compensation | $5.3M | $5.7M | $6.3M | $5.5M | $6.6M | $7.0M | $6.4M | $10.8M |
| Deferred income taxes | — | — | — | — | — | — | — | — |
| Change in accounts payable | -$851.0K | $454.0K | -$189.0K | -$357.0K | $1.2M | -$4.2M | $2.3M | -$507.0K |
| Purchases of investments | $101.7M | $5.6M | $36.1M | $49.5M | $0 | $1.7M | $13.1M | $36.0M |
| Other investing activities | — | — | — | — | — | — | — | — |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating income | -$250.3M | -$272.7M | -$293.1M | -$272.6M | -$356.9M |
| Net income | -$244.2M | -$266.8M | -$283.3M | -$269.5M | -$355.9M |
| EPS (diluted) | $-0.96 | $-1.16 | $-1.46 | $-1.43 | $-2.14 |
| EPS (basic) | $-0.96 | $-1.16 | $-1.46 | $-1.43 | $-2.14 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $416.9M | $501.0M | $565.3M | $822.7M | $1.13B |
| Total liabilities | $256.0M | $250.5M | $277.8M | $323.4M | $400.9M |
| Stockholders' equity | $160.9M | $250.5M | $287.5M | $499.3M | $728.5M |
| Total current assets | $148.7M | $160.8M | $213.5M | $444.4M | $558.1M |
| Total current liabilities | $78.7M | $45.4M | $64.5M | $111.5M | $99.2M |
| Cash & equivalents | $71.9M | $127.6M | $133.5M | $176.8M | $253.0M |
| Marketable securities (current) | $66.5M | $24.9M | $71.7M | $247.2M | $298.0M |
| Marketable securities (non-current) | — | — | — | $10.1M | $195.9M |
| Property, plant & equipment | $26.9M | $77.3M | $70.7M | $66.9M | $65.5M |
| Goodwill | $140.6M | $140.6M | $140.6M | $140.6M | $140.6M |
| Intangible assets | $59.2M | $59.2M | $59.2M | $59.2M | $59.2M |
| Other non-current assets | $3.2M | $5.1M | $6.4M | $4.6M | $5.0M |
| Accounts payable | $1.7M | $5.2M | $4.1M | $2.9M | $2.2M |
| Other non-current liabilities | $10.6M | $9.9M | — | — | — |
| Common stock & paid-in capital | $27.0K | $22.0K | $20.0K | $19.0K | $18.0K |
| Retained earnings | -$1.85B | -$1.60B | -$1.34B | -$1.05B | -$785.4M |
| Accumulated other comprehensive income (loss) | $28.0K | $14.0K | -$60.0K | -$4.3M | -$1.4M |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | -$143.8M | -$223.2M | -$253.6M | -$290.1M | -$251.1M |
| Investing cash flow | -$40.2M | $17.5M | $172.0M | $210.6M | -$245.8M |
| Financing cash flow | $128.7M | $199.7M | $31.6M | $4.9M | $631.8M |
| Free cash flow | -$144.8M | -$256.6M | -$273.6M | -$310.9M | -$280.9M |
| Capital expenditures | $938.0K | $33.4M | $20.0M | $20.9M | $29.9M |
| Share-based compensation | $25.5M | $37.7M | $35.5M | $38.3M | $22.4M |
| Deferred income taxes | — | — | — | — | — |
| Change in accounts payable | -$3.5M | $1.4M | $1.0M | $1.1M | -$266.0K |
| Purchases of investments | $87.3M | $226.1M | $157.7M | $78.7M | $491.4M |
| Other investing activities | — | — | — | — | $4.6M |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding SANA as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Institutional ownership is not available for this symbol right now.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2025-06-03 to 2026-10-05
Recent transactions
- Most recent: Bishop Hans Edgar (Reporting person) — Grant / award of 8,680 shares on 2026-10-05.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)0 sh(0 txns)
Sales (open market)0 sh(0 txns)
Net Shares+0
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Bishop Hans Edgar | Reporting person | Grant / award | 2026-10-05 | 8,680 |
| PATEL DHAVALKUMAR DHIRAJLAL | EVP, Chief Scientific Officer | Tax withholding | 2026-08-27 | 41,158 |
| Harr Steve | President & CEO | Tax withholding | 2026-03-09 | 11,526 |
| Wyrick Susan D. | See Remarks | Tax withholding | 2026-03-09 | 3,342 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-10-05 | Bishop Hans Edgar | Reporting person | Grant / award | 8,680 | $0.00 |
| 2026-08-27 | PATEL DHAVALKUMAR DHIRAJLAL | EVP, Chief Scientific Officer | Tax withholding | 41,158 | $4.11 |
| 2026-08-26 | PATEL DHAVALKUMAR DHIRAJLAL | EVP, Chief Scientific Officer | Option exercise | 125,000 | $0.00 |
| 2026-07-06 | Bishop Hans Edgar | Reporting person | Grant / award | 6,297 | $0.00 |
| 2026-04-06 | Bishop Hans Edgar | Reporting person | Grant / award | 7,763 | $0.00 |
| 2026-03-09 | Harr Steve | President & CEO | Tax withholding | 11,526 | $3.13 |
| 2026-03-09 | Harr Steve | President & CEO | Tax withholding | 12,819 | $3.10 |
| 2026-03-09 | Wyrick Susan D. | See Remarks | Tax withholding | 3,342 | $3.13 |
| 2026-03-09 | Wyrick Susan D. | See Remarks | Tax withholding | 1,045 | $3.10 |
| 2026-03-07 | Harr Steve | President & CEO | Option exercise | 50,000 | $0.00 |
| 2026-03-07 | Wyrick Susan D. | See Remarks | Option exercise | 3,250 | $0.00 |
| 2026-03-06 | Harr Steve | President & CEO | Option exercise | 41,666 | $0.00 |
| 2026-03-06 | Wyrick Susan D. | See Remarks | Option exercise | 10,416 | $0.00 |
| 2026-03-03 | Wyrick Susan D. | See Remarks | Tax withholding | 491 | $3.91 |
| 2026-03-02 | Wyrick Susan D. | See Remarks | Option exercise | 1,525 | $0.00 |
| 2026-01-05 | Bishop Hans Edgar | Reporting person | Grant / award | 6,157 | $0.00 |
| 2026-01-05 | Wyrick Susan D. | See Remarks | Tax withholding | 2,407 | $4.27 |
| 2026-01-02 | Wyrick Susan D. | See Remarks | Option exercise | 7,500 | $0.00 |
| 2025-12-15 | Wyrick Susan D. | See Remarks | Tax withholding | 873 | $5.22 |
| 2025-12-13 | Wyrick Susan D. | See Remarks | Option exercise | 3,400 | $0.00 |
| 2025-12-04 | Wyrick Susan D. | See Remarks | Tax withholding | 2,565 | $4.44 |
| 2025-12-03 | Wyrick Susan D. | See Remarks | Option exercise | 10,000 | $0.00 |
| 2025-10-06 | Bishop Hans Edgar | Reporting person | Grant / award | 5,628 | $0.00 |
| 2025-07-07 | Bishop Hans Edgar | Reporting person | Grant / award | 7,842 | $0.00 |
| 2025-06-04 | Wyrick Susan D. | See Remarks | Tax withholding | 2,567 | $2.32 |
| 2025-06-03 | Wyrick Susan D. | See Remarks | Option exercise | 10,000 | $0.00 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-22 07:48 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-10-06 | 4 | 2026-10-05 | View on SEC.gov → |
| 2026-09-08 | 8-K | 2026-09-08 | View on SEC.gov → |
| 2026-08-27 | 4 | 2026-08-26 | View on SEC.gov → |
| 2026-08-10 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-08-10 | 8-K | 2026-08-10 | View on SEC.gov → |
| 2026-07-07 | 4 | 2026-07-06 | View on SEC.gov → |
| 2026-06-05 | 4 | 2026-06-04 | View on SEC.gov → |
| 2026-06-05 | 4 | 2026-06-04 | View on SEC.gov → |
| 2026-06-05 | 4 | 2026-06-04 | View on SEC.gov → |
| 2026-06-05 | 4 | 2026-06-04 | View on SEC.gov → |
| 2026-06-05 | 4 | 2026-06-04 | View on SEC.gov → |
| 2026-06-05 | 4 | 2026-06-04 | View on SEC.gov → |
Recent news
Headlines about SANA (Sana Biotechnology, Inc.). Links open the publisher — we don’t host full articles.
-
Workday (WDAY) Lands Gartner Leader Nod As Sana Debut Deepens Its AI Push
Simply Wall Street · 2026-10-22 -
The Wizard Feast: An Enchanted Halloween Dining Experience at Sana Sini Restaurant
Indonesia Expat · 2026-10-21 -
Sana Javed showers love and pride on husband Shoaib Malik
Bol News · 2026-10-16 -
Indian Idol Legends Return: Abhijeet Sawant, Amit Sana, Salman Ali among 24 singers to compete; Himesh...
Moneycontrol.com · 2026-10-16 -
Fatima Sana Shaikh's Royal Enfield - 5 Bollywood actresses who are avid bikers and have a Royal Enfield
The Economic Times · 2026-10-16 -
SANA270416C00005000 Interactive Stock Chart | SANA Apr 2027 5.000 call Stock - Yahoo Finance
Yahoo! Finance Canada · 2026-10-16 -
‘One of the biggest challenges of riding is people’s perception’: Fatima Sana Shaikh
The Times of India · 2026-10-16 -
Sana Biotechnology: A Shot At Diabetes
SeekingAlpha · 2026-10-13
No headlines in this category right now — try “All”.